| pubmed-article:18793832 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18793832 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:18793832 | lifeskim:mentions | umls-concept:C0037369 | lld:lifeskim |
| pubmed-article:18793832 | lifeskim:mentions | umls-concept:C0035647 | lld:lifeskim |
| pubmed-article:18793832 | lifeskim:mentions | umls-concept:C0684249 | lld:lifeskim |
| pubmed-article:18793832 | lifeskim:mentions | umls-concept:C0024117 | lld:lifeskim |
| pubmed-article:18793832 | lifeskim:mentions | umls-concept:C0001617 | lld:lifeskim |
| pubmed-article:18793832 | lifeskim:mentions | umls-concept:C0004048 | lld:lifeskim |
| pubmed-article:18793832 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:18793832 | pubmed:dateCreated | 2009-1-2 | lld:pubmed |
| pubmed-article:18793832 | pubmed:abstractText | COPD is associated with an increased risk of lung cancer. We examined whether inhaled corticosteroids (ICS) used concomitantly with long-acting beta(2)-agonists (LABA) were associated with reduction in lung cancer risk in COPD patients. | lld:pubmed |
| pubmed-article:18793832 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18793832 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18793832 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:18793832 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18793832 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18793832 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18793832 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18793832 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:18793832 | pubmed:issn | 1532-3064 | lld:pubmed |
| pubmed-article:18793832 | pubmed:author | pubmed-author:SorianoJoan... | lld:pubmed |
| pubmed-article:18793832 | pubmed:author | pubmed-author:FabbriLeonard... | lld:pubmed |
| pubmed-article:18793832 | pubmed:author | pubmed-author:DavisKourtney... | lld:pubmed |
| pubmed-article:18793832 | pubmed:author | pubmed-author:KiriVictor... | lld:pubmed |
| pubmed-article:18793832 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:18793832 | pubmed:volume | 103 | lld:pubmed |
| pubmed-article:18793832 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18793832 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18793832 | pubmed:pagination | 85-90 | lld:pubmed |
| pubmed-article:18793832 | pubmed:meshHeading | pubmed-meshheading:18793832... | lld:pubmed |
| pubmed-article:18793832 | pubmed:meshHeading | pubmed-meshheading:18793832... | lld:pubmed |
| pubmed-article:18793832 | pubmed:meshHeading | pubmed-meshheading:18793832... | lld:pubmed |
| pubmed-article:18793832 | pubmed:meshHeading | pubmed-meshheading:18793832... | lld:pubmed |
| pubmed-article:18793832 | pubmed:meshHeading | pubmed-meshheading:18793832... | lld:pubmed |
| pubmed-article:18793832 | pubmed:meshHeading | pubmed-meshheading:18793832... | lld:pubmed |
| pubmed-article:18793832 | pubmed:meshHeading | pubmed-meshheading:18793832... | lld:pubmed |
| pubmed-article:18793832 | pubmed:meshHeading | pubmed-meshheading:18793832... | lld:pubmed |
| pubmed-article:18793832 | pubmed:meshHeading | pubmed-meshheading:18793832... | lld:pubmed |
| pubmed-article:18793832 | pubmed:meshHeading | pubmed-meshheading:18793832... | lld:pubmed |
| pubmed-article:18793832 | pubmed:meshHeading | pubmed-meshheading:18793832... | lld:pubmed |
| pubmed-article:18793832 | pubmed:meshHeading | pubmed-meshheading:18793832... | lld:pubmed |
| pubmed-article:18793832 | pubmed:meshHeading | pubmed-meshheading:18793832... | lld:pubmed |
| pubmed-article:18793832 | pubmed:meshHeading | pubmed-meshheading:18793832... | lld:pubmed |
| pubmed-article:18793832 | pubmed:meshHeading | pubmed-meshheading:18793832... | lld:pubmed |
| pubmed-article:18793832 | pubmed:meshHeading | pubmed-meshheading:18793832... | lld:pubmed |
| pubmed-article:18793832 | pubmed:meshHeading | pubmed-meshheading:18793832... | lld:pubmed |
| pubmed-article:18793832 | pubmed:meshHeading | pubmed-meshheading:18793832... | lld:pubmed |
| pubmed-article:18793832 | pubmed:meshHeading | pubmed-meshheading:18793832... | lld:pubmed |
| pubmed-article:18793832 | pubmed:meshHeading | pubmed-meshheading:18793832... | lld:pubmed |
| pubmed-article:18793832 | pubmed:meshHeading | pubmed-meshheading:18793832... | lld:pubmed |
| pubmed-article:18793832 | pubmed:meshHeading | pubmed-meshheading:18793832... | lld:pubmed |
| pubmed-article:18793832 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:18793832 | pubmed:articleTitle | Inhaled corticosteroids and risk of lung cancer among COPD patients who quit smoking. | lld:pubmed |
| pubmed-article:18793832 | pubmed:affiliation | Worldwide Epidemiology, GlaxoSmithKline R&D, Greenford, UK. victor.kiri@parexel.com | lld:pubmed |
| pubmed-article:18793832 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:18793832 | pubmed:publicationType | Comparative Study | lld:pubmed |
